Time to onset of bisphosphonate‐related osteonecrosis of the jaws: a multicentre retrospective cohort study - Fung, PPL; Bedogni, G; Bedogni, A; Petrie, A; Porter, S; Campisi, G; Bagan, J; Fusco, V; Saia, G; Acham, S; Musto, P; Petrucci, MT; et al. (Oral Diseases, 2017)
Keywords: 80 and over; Adult; Aged; Aged, 80 and over; bisphosphonate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bisphosphonate-Associated Osteonecrosis of the Jaw - epidemiology; Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology; bisphosphonates; bisphosphonates; breast cancer; jaw osteonecrosis; multiple myeloma; osteoporosis; prostate cancer; bisphosphonates; breast cancer; jaw osteonecrosis; multiple myeloma; osteoporosis; prostate cancer; Adult; Aged; Aged, 80 and over; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cross-Sectional Studies; Diphosphonates; Drug Administration Schedule; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Time Factors; Otorhinolaryngology; 2734; Pathology and Forensic Medicine; Dentistry (all); Bisphosphonates; Breast cancer; Jaw osteonecrosis; Multiple myeloma; Osteoporosis; Prostate cancer; Otorhinolaryngology2734 Pathology and Forensic Medicine; Dentistry (all); Bone Density Conservation Agents; Bone Density Conservation Agents - administration & dosage; Bone Density Conservation Agents - adverse effects; breast cancer; Cross-Sectional Studies; Dentistry (all); Diphosphonates; Diphosphonates - administration & dosage; Diphosphonates - adverse effects; Drug Administration Schedule; Female; Humans; Incidence; jaw osteonecrosi; jaw osteonecrosis; jaw osteonecrosis, bisphosphonates, breast cancer, multiple myeloma, prostate cance, osteoporosis; jaw osteonecrosis; bisphosphonates; breast cancer; multiple myeloma; prostate cancer; osteoporosis; Male; Middle Aged; multiple myeloma; Multivariate Analysis; osteoporosi; osteoporosis; Otorhinolaryngology2734 Pathology and Forensic Medicine; Proportional Hazards Models; prostate cancer; Retrospective Studies; Risk Factors; Time Factors; breast cancer; jaw osteonecrosis; multiple myeloma; prostate cancer; bisphosphonates; osteoporosis